Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 47, Issue 9, Pages 4375-4392
Publisher
Oxford University Press (OUP)
Online
2019-03-19
DOI
10.1093/nar/gkz214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Exosomes and extracellular vesicles: the path forward
- (2018) Philip D. Stahl et al. Essays in Biochemistry
- Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides
- (2018) Shiyu Wang et al. NUCLEIC ACIDS RESEARCH
- Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation
- (2018) Colton M. Miller et al. Nucleic Acid Therapeutics
- COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways
- (2018) Xue-hai Liang et al. NUCLEIC ACIDS RESEARCH
- Cellular uptake and trafficking of antisense oligonucleotides
- (2017) Stanley T Crooke et al. NATURE BIOTECHNOLOGY
- Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs
- (2017) Xue-Hai Liang et al. NUCLEIC ACIDS RESEARCH
- Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides
- (2017) Shiyu Wang et al. NUCLEIC ACIDS RESEARCH
- Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS
- (2017) Sarah J. Ross et al. Science Translational Medicine
- Molecular Mechanisms of Antisense Oligonucleotides
- (2017) Stanley T. Crooke Nucleic Acid Therapeutics
- Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity
- (2016) Seiichi Odate et al. CLINICAL CANCER RESEARCH
- K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis
- (2016) Tao Li et al. MEDICAL ONCOLOGY
- Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames
- (2016) Xue-hai Liang et al. NATURE BIOTECHNOLOGY
- Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver
- (2016) Colton M. Miller et al. NUCLEIC ACIDS RESEARCH
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- BORC Functions Upstream of Kinesins 1 and 3 to Coordinate Regional Movement of Lysosomes along Different Microtubule Tracks
- (2016) Carlos M. Guardia et al. Cell Reports
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
- (2015) Timothy A. Vickers et al. NUCLEIC ACIDS RESEARCH
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Extracellular p53 fragment re-enters K-Ras mutated cells through the caveolin-1 dependent early endosomal system
- (2015) Sun-Hye Lee et al. Oncotarget
- Antisense oligonucleotides in cancer
- (2014) Daniela Castanotto et al. CURRENT OPINION IN ONCOLOGY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Rab5 Isoforms Orchestrate a “Division of Labor” in the Endocytic Network; Rab5C Modulates Rac-Mediated Cell Motility
- (2014) Pin-I Chen et al. PLoS One
- Endosome maturation, transport and functions
- (2014) Cameron C. Scott et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression
- (2013) Ming-Chung Jiang et al. AMERICAN JOURNAL OF SURGERY
- Late endosomal and lysosomal trafficking during integrin-mediated cell migration and invasion
- (2013) Elena Rainero et al. BIOESSAYS
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Rapid Measurement of Intracellular Unbound Drug Concentrations
- (2013) André Mateus et al. MOLECULAR PHARMACEUTICS
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
- (2013) Cosimo Commisso et al. NATURE
- Rab5c promotes AMAP1–PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
- (2012) Yasuhito Onodera et al. JOURNAL OF CELL BIOLOGY
- Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides
- (2012) R. L. Juliano et al. JOURNAL OF DRUG TARGETING
- TricycloDNA-modified oligo-2′-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues—a comparative study of oligonucleotide length, design and chemistry
- (2012) Sue Murray et al. NUCLEIC ACIDS RESEARCH
- Cellular Uptake and Intracellular Trafficking of Antisense and siRNA Oligonucleotides
- (2011) Rudolph L. Juliano et al. BIOCONJUGATE CHEMISTRY
- The munc13-4-rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane
- (2011) E. D. Elstak et al. BLOOD
- Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis
- (2011) Xin Ming Expert Opinion on Drug Delivery
- Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
- (2011) Erich Koller et al. NUCLEIC ACIDS RESEARCH
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Identification of the Switch in Early-to-Late Endosome Transition
- (2010) Dmitry Poteryaev et al. CELL
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Delayed Onset of Positive Feedback Activation of Rab5 by Rabex-5 and Rabaptin-5 in Endocytosis
- (2010) Huaiping Zhu et al. PLoS One
- Rab5 Isoforms Differentially Regulate the Trafficking and Degradation of Epidermal Growth Factor Receptors
- (2009) Pin-I Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Biological Effect of an Antisense Oligonucleotide Depends on Its Route of Endocytosis and Trafficking
- (2009) Md. Rowshon Alam et al. OLIGONUCLEOTIDES
- Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals
- (2008) Punit P. Seth et al. JOURNAL OF MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started